These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

710 related items for PubMed ID: 10493212

  • 1. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
    Ohkura N, Soe G, Kohno I, Kumeda K, Wada H, Kamikubo Y, Shiku H, Kato H.
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
    [Abstract] [Full Text] [Related]

  • 2. Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation.
    Okugawa Y, Wada H, Noda T, Sakakura M, Nakasaki T, Watanabe R, Deguchi H, Gabazza EC, Mori Y, Nishikawa M, Deguchi K, Nobori T, Shiku H.
    Am J Hematol; 2000 Nov; 65(3):210-4. PubMed ID: 11074537
    [Abstract] [Full Text] [Related]

  • 3. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
    Shimura M, Wada H, Wakita Y, Nakase T, Hiyoyama K, Nagaya S, Mori Y, Shiku H.
    Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
    [Abstract] [Full Text] [Related]

  • 4. Tissue factor pathway inhibitor; its structure, function and clinical significance.
    Kato H.
    Pol J Pharmacol; 1996 Jul; 48(1):67-72. PubMed ID: 9112630
    [Abstract] [Full Text] [Related]

  • 5. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S.
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [Abstract] [Full Text] [Related]

  • 6. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.
    Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Deguchi H, Mori Y, Kaneko T, Deguchi K, Fujii J, Shiku H.
    Am J Hematol; 1996 Apr; 51(4):255-60. PubMed ID: 8602623
    [Abstract] [Full Text] [Related]

  • 7. [Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases].
    Saito M, Morishita E, Asakura H, Jokaji H, Uotani C, Kumabashiri I, Yamazaki M, Aoshima K, Matsuda T.
    Rinsho Ketsueki; 1996 Sep; 37(9):794-8. PubMed ID: 8914465
    [Abstract] [Full Text] [Related]

  • 8. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA, Dempfle CE, Matsuda M, Heene DL.
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [Abstract] [Full Text] [Related]

  • 9. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
    Bregengård C, Nordfang O, Wildgoose P, Svendsen O, Hedner U, Diness V.
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
    [Abstract] [Full Text] [Related]

  • 10. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
    Fukuda C, Iijima K, Nakamura K.
    Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
    [Abstract] [Full Text] [Related]

  • 11. The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa.
    Peraramelli S, Suylen DP, Rosing J, Hackeng TM.
    Thromb Haemost; 2012 Aug; 108(2):266-76. PubMed ID: 22627666
    [Abstract] [Full Text] [Related]

  • 12. Factor Xa cleavage of tissue factor pathway inhibitor is associated with loss of anticoagulant activity.
    Salemink I, Franssen J, Willems GM, Hemker HC, Li A, Wun TC, Lindhout T.
    Thromb Haemost; 1998 Aug; 80(2):273-80. PubMed ID: 9716152
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
    Seo JW, Kim HK, Kim JE, Park S, Cho HI.
    Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738
    [Abstract] [Full Text] [Related]

  • 15. Anti-heparin/PF4 complexes by ELISA in patients with disseminated intravascular coagulation.
    Matsuo T, Matsuo M, Sugimoto T, Wanaka K.
    Pathophysiol Haemost Thromb; 2007 Feb; 36(6):305-10. PubMed ID: 20224256
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
    Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Mori Y, Deguchi K, Shiku H.
    Pol J Pharmacol; 1996 Feb; 48(2):225-8. PubMed ID: 9112656
    [Abstract] [Full Text] [Related]

  • 17. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
    Iakhiaev A, Ruf W, Rao LV.
    Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
    [Abstract] [Full Text] [Related]

  • 18. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
    Okajima K, Uchiba M, Murakami K, Okabe H, Takatsuki K.
    Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
    [Abstract] [Full Text] [Related]

  • 19. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M, Ranlall N, Patel G, Rutlin A, Jehanli A, Kakkar VV.
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809
    [Abstract] [Full Text] [Related]

  • 20. Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain.
    Augustsson C, Svensson A, Kjaer B, Chao TY, Wenjuan X, Krogh BO, Breinholt J, Clausen JT, Hilden I, Petersen HH, Petersen LC.
    J Thromb Haemost; 2018 May; 16(5):893-904. PubMed ID: 29532595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.